Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 1,576 | 3,336 | 2,658 | 1,717 | 1,821 |
| Gross Profit | 1,576 | 3,336 | 2,658 | 1,717 | 1,821 |
| Operating Expenses | 11,210 | 12,151 | 13,041 | 14,385 | 15,654 |
| Operating Income | -9,634 | -8,815 | -10,383 | -12,668 | -13,833 |
| Interest Expense | 152 | 188 | 215 | 241 | 357 |
| Other Income | 290 | 343 | 427 | 562 | 756 |
| Pre-tax Income | -9,496 | -8,660 | -10,171 | -12,347 | -13,434 |
| Net Income Continuous | -9,496 | -8,660 | -10,171 | -12,347 | -13,434 |
| Net Income | $-9,496 | $-8,660 | $-10,171 | $-12,347 | $-13,434 |
| EPS Basic Total Ops | -3.00 | -5.11 | -6.01 | -7.51 | -8.71 |
| EPS Basic Continuous Ops | -3.03 | -5.08 | -6.09 | -7.50 | -8.51 |
| EPS Diluted Total Ops | -3.00 | -5.11 | -6.01 | -7.51 | -8.71 |
| EPS Diluted Continuous Ops | -3.03 | -5.08 | -6.09 | -7.50 | -8.51 |
| EPS Diluted Before Non-Recurring Items | -3.90 | -5.11 | -6.01 | N/A | N/A |
| EBITDA(a) | $-9,527 | $-8,704 | $-10,275 | $-12,560 | $-13,711 |